David Palmer, MD
Otolaryngology · Slc, UTNPI 1427018191
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $2,124 of the $3,487 with a category attached, or 60.9%. 22 manufacturers reported payments, led by Smith+Nephew at 43.5% of the total. Reporting peaked in 2023 at $1,857 and has fallen 91.3% since, to $162 in 2025.
Across 107 payments — averaging $32.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Smith+Nephew$2K
- Regeneron Healthcare Solutions, Inc.$471
- Sanofi$418
- Optinose US, Inc.$257
- GSK$224
- AstraZeneca$149
- plus $451 from 16 others
What the payments were for
- Travel & lodging$1,35139%
- Food & beverage$2,12461%
- Other$130%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Smith+Nephew | 6 | $1,517 |
| Regeneron Healthcare Solutions, Inc. | 20 | $471 |
| Sanofi | 21 | $418 |
| Optinose US, Inc. | 14 | $257 |
| GSK | 17 | $224 |
| AstraZeneca | 7 | $149 |
| Novartis | 5 | $76 |
| Revance Therapeutics, Inc. | 1 | $60 |
| Aerin Medical Inc. | 2 | $51 |
| Medtronic | 1 | $39 |
| Amgen | 2 | $36 |
| Stryker | 1 | $21 |
| Inspire Medical Systems, Inc. | 1 | $20 |
| Sanofi-aventis U.S. LLC | 1 | $20 |
| Acell, Inc. | 1 | $19 |
| Intersect ENT, Inc. | 1 | $18 |
| Kaleo, Inc. | 1 | $17 |
| Circassia Inc. | 1 | $16 |
| Arbor Pharmaceuticals, Inc. | 1 | $15 |
| ZOLL Respicardia, Inc. | 1 | $15 |
| Merck | 1 | $14 |
| Welch Allyn | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,487 in reported general payments places this provider in the 75th percentile of 104 otolaryngology providers in Utah.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Famotidine | 393 | $4,573 |
| Pantoprazole Sodium | 291 | $3,044 |
| Ipratropium Bromide | 113 | $2,427 |
| Omeprazole | 142 | $2,311 |
| Dexlansoprazole DrDexlansoprazole | 13 | $1,699 |
| Fluticasone Propionate | 90 | $1,192 |
| Doxycycline Monohydrate | 31 | $347 |
| Lansoprazole | 11 | $237 |
| Montelukast Sodium | 18 | $64 |
Paid to pharmacies, not to this prescriber.
Other otolaryngology in Slc
- Jerry SonkensSlc$12K
- John ButlerSlc$2K
- John BitnerLayton$177K
- Steven MillerSalt Lake City$32K
- Michael WilsonSalt Lake City$16K
- Kevin WilsonDraper$13K
- Matthew DahlSalt Lake City$12K
- Seth RiddleProvo$10K
- Heidi HerasAmerican Fork$9K
- Douglas AndersonOgden$9K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.